The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Treatment of dual diagnosis disorders
Abstract
PURPOSE OF REVIEW: Treatment of dual diagnosis [co-occurrence of a substance use disorder (SUD) in patients with mental illness] poses several challenges for mental health professionals. This article seeks to review the recent advances in dual diagnosis treatment with respect to pharmacotherapy and psychosocial approaches. RECENT FINDINGS: Atypical antipsychotics are commonly used for comorbid schizophrenia and SUD. Whereas there is no difference between risperidone and olanzapine, clozapine appears to have a distinct advantage in reducing psychotic symptoms as well as substance abuse (including smoking). There is emerging evidence that quetiapine is beneficial in dually diagnosed patients, particularly using alcohol, cocaine and amphetamine. A combination of naltrexone and sertraline was found to be effective in patients with depressive disorder and alcohol dependence. Effectiveness of atomoxetine is yet to be established in patients with comorbid adult attention-deficit/hyperactivity disorder with respect to decrease in substance abuse. Integrated intervention is the choice of treatment for patients with dual diagnosis. SUMMARY: In spite of the high association between substance use and psychiatric disorders, there is a surprising paucity of studies related to treatment and outcome. A few well-designed studies have been recently published and more studies of this nature are required in order to address the challenges posed in the treatment of dual disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Integrated care models, which combine SUD and mental health treatment, have demonstrated efficacy in improving outcomes for this complex population [18].”
From Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review (2024) · cites this paper as [18]
Citations
Cites
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., Pickering, R. P., & Kaplan, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.807 · Cited by 2,889
Merikangas, K. R., Ames, M., Cui, L., Stang, P. E., Ustun, T. B., Von Korff, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1180 · Cited by 464
Psychosocial Approaches to Dual Diagnosis
Drake, R. E., & Mueser, K. T. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033429 · Cited by 308
Treatment of substance abusing patients with comorbid psychiatric disorders
Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.09.010 · Cited by 306
Bellack, A. S., Bennett, M. E., Gearon, J. S., Brown, C. H., & Yang, Y. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.4.426 · Cited by 285
Salloum, I. M., Cornelius, J. R., Daley, D. C., Kirisci, L., Himmelhoch, J. M., & Thase, M. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.1.37 · Cited by 271
Pettinati, H. M., Oslin, D. W., Kampman, K. M., Dundon, W. D., Xie, H., Gallis, T. L., Dackis, C. A., & O’Brien, C. P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08060852 · Cited by 268
The Effects of Clozapine on Alcohol and Drug Use Disorders Among Patients With Schizophrenia
Drake, R. E., Xie, H., McHugo, G. J., & Green, A. I. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033464 · Cited by 253
Barrowclough, C., Haddock, G., Wykes, T., Beardmore, R., Conrod, P., Craig, T., Davies, L. M., Dunn, G., Eisner, E., Lewis, S. W., et al. (2010) · BMJ · doi:10.1136/bmj.c6325 · Cited by 245
Substance use and addiction research in India
Murthy, P., Manjunatha, N., Subodh, B. N., Chand, P., & Benegal, V. (2010) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.69232 · Cited by 196
Treatments for Patients With Dual Diagnosis: A Review
Tiêt, Q. Q., & Mausbach, B. T. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00336.x · Cited by 172
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders
Wilens, T. E., Adler, L. A., Weiss, M. D., Michelson, D., Ramsey, J. L., Moore, R. J., Renard, D., Brady, K. T., Trzepacz, P. T., Schuh, L. M., et al. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.02.009 · Cited by 171
Dual Diagnosis: 15 Years of Progress
Drake, R. E., & Wallach, M. A. (2000) · Psychiatric Services · doi:10.1176/appi.ps.51.9.1126 · Cited by 167
Substance abuse and schizophrenia: Pharmacotherapeutic intervention
Green, A. I., Noordsy, D. L., Brunette, M. F., & O’Keefe, C. D. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.01.008 · Cited by 157
Antidepressant treatment of co-occurring depression and alcohol dependence
Pettinati, H. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.016 · Cited by 141
Petrakis, I. L., Poling, J. C., Levinson, C. M., Nich, C., Carroll, K. M., Ralevski, E., & Rounsaville, B. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.074 · Cited by 125
Brown, E. S., Garza, M. J., & Carmody, T. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0502 · Cited by 101
Schizophrenia outcome measures in the wider international community
Isaac, M., Chand, P., & Murthy, P. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.50.s71 · Cited by 101
Treatment of Cannabis Use Among People With Psychotic or Depressive Disorders
Baker, A., Hides, L. M., & Lubman, D. I. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05119gry · Cited by 98
Thurstone, C., Riggs, P. D., Salomonsen-Sautel, S., & Mikulich-Gilbertson, S. K. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.02.013 · Cited by 96
Brown, E. S., Carmody, T. J., Schmitz, J. M., Caetano, R., Adinoff, B. H., Swann, A. C., & Rush, A. J. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01024.x · Cited by 93
McRae‐Clark, A. L., Carter, R. E., Killeen, T. K., Carpenter, M. J., White, K., & Brady, K. T. (2010) · American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00076.x · Cited by 90
Martinotti, G., Andreoli, S., Nicola, M. D., Giannantonio, M. D., Sarchiapone, M., & Janiri, L. (2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.944 · Cited by 89
HUSSAIN, M. Z., WAHEED, W., & HUSSAIN, S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.9.1755-a · Cited by 72
Stedman, M., Pettinati, H. M., Brown, E. S., Kotz, M., Calabrese, J. R., & Raines, S. (2010) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01270.x · Cited by 70
Anxiety Disorders with Comorbid Substance Use Disorders: Diagnostic and Treatment Considerations
Back, S. E., & Brady, K. T. (2008) · Psychiatric Annals · doi:10.3928/00485713-20081101-01 · Cited by 69
Intravenous Quetiapine-Cocaine Use ("Q-Ball")
WATERS, B. M., & Joshi, K. G. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.1.173a · Cited by 67
Relationship between anxiety disorders and opiate dependence— A systematic review of the literature
Fatseas, M., Denis, C., Lavie, E., & Auriacombe, M. (2010) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.12.003 · Cited by 62
Machielsen, M. W. J., Beduin, A. S., Dekker, N., Kahn, R. S., LINSZEN, D. H., van Os, J., Wiersma, D., Bruggeman, R., Cahn, W., de Haan, L., et al. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408957 · Cited by 62
Reduction of Opioid-Withdrawal Symptoms With Quetiapine
Pinkofsky, H. B., Hahn, A. M., Campbell, F. A., Rueda, J., Daley, D. C., & Douaihy, A. B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1011 · Cited by 47
Antipsychotic Drug Treatment of Schizophrenic Patients with Substance Abuse Disorders
San, L., Arranz, B., & Martı́nez-Raga, J. (2007) · European Addiction Research · doi:10.1159/000104886 · Cited by 40
Morrens, M., Dewilde, B., Sabbe, B., Dom, G., Cuyper, R. D., & Moggi, F. (2011) · European Addiction Research · doi:10.1159/000324480 · Cited by 40
Dutra, S. J., Stoeckel, L. E., Carlini, S. V., Pizzagalli, D. A., & Evins, A. E. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2373-6 · Cited by 40
Sevy, S. M., Robinson, D. G., Sunday, S. R., Napolitano, B. A., Miller, R., McCormack, J., & Kane, J. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.05.001 · Cited by 37
The effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia
Kim, S. H., Han, D. H., Joo, S. Y., & Min, K. J. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1089 · Cited by 32
Zhornitsky, S., Stip, É., Pampoulova, T., Rizkallah, É., Lipp, O., Bentaleb, L. A., Chiasson, J., & Potvin, S. (2010) · Movement Disorders · doi:10.1002/mds.23227 · Cited by 27
Quetiapine for the Treatment of Cocaine Dependence
Kennedy, A., Wood, A. E., Saxon, A. J., Malte, C. A., Harvey, M., Jurik, J., Kilzieh, N., Lofgreen, C., & Tapp, A. M. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318166f50d · Cited by 27
New clinical strategies of assessment of comorbidity associated with substance use disorders
Cosci, F., & Fava, G. A. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.11.004 · Cited by 27
Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism
Garay, R. P. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6741 · Cited by 24
Ralevski, E., O’Brien, E. M., Jane, J. S., Dean, E., Dwan, R., & Petrakis, I. L. (2011) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3182214297 · Cited by 23
Research works printed but not linked: 3
- Sattar, 2007, Valproate in the treatment of bipolar disorder and comorbid substance abuse: a 24-week open label trial., Biol Psychiatry, 61, 46S
- Erdogan, 2010, Quetiapine in substance use disorders, abuse and dependence possibility: a review in Turkish., Turk Psikiyatri Derg, 21, 167
- Hides, 2011, Does the addition of integrated cognitive behaviour therapy and motivational interviewing improve the outcomes of standard care for young people with comorbid depression and substance misuse Med J, Aust, 195, S31
Cited by
Sorted by citations
Integrated treatment of substance use and psychiatric disorders
Kelly, T. M., & Daley, D. C. (2013) · Social Work in Public Health · doi:10.1080/19371918.2013.774673 · Cited by 378
Connor, J. P., Haber, P. S., & Hall, W. D. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00122-1 · Cited by 389
Psychosocial Interventions for People With Both Severe Mental Illness and Substance Misuse
Hunt, G. E., Siegfried, N., Morley, K. C., Sitharthan, T., & Cleary, M. L. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt160 · Cited by 282
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J. A., Glenthoj, B. Y., Gattaz, W. F., Thibaut, F., Möller, H., & on behalf of the WFSBP Task Force on Treatment Guidelines for Schizophrenia (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1009163 · Cited by 147
Morisano, D., Babor, T. F., & Robaina, K. (2014) · Nordic Studies on Alcohol and Drugs · doi:10.2478/nsad-2014-0002 · Cited by 119
Metadata
- Authors
- Murthy, P., & Chand, P.
- Affiliations
- National Institute of Mental Health and Neurosciences (IN)
- Corresponding author
- Murthy, Pratima
- Venue
- Current Opinion in Psychiatry
- Published
- 2012-05
- Volume
- 25
- Issue
- 3
- Pages
- 194-200
- ISSN
- 0951-7367 (ISSN-L)
- OpenAlex
- W2067425226
- Cited by
- 115
- References
- 42
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 10 · 2023: 3 · 2022: 7 · 2021: 12 · 2020: 4 · 2019: 8 · 2018: 7 · 2017: 8 · 2016: 11 · 2015: 11 · 2014: 15 · 2013: 10
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- dual diagnosis, substance use disorders, psychiatric comorbidity, pharmacotherapy, psychosocial interventions, atypical antipsychotics, clozapine, risperidone, olanzapine, quetiapine, naltrexone, sertraline, atomoxetine, integrated intervention, alcoholism, smoking, cocaine, amphetamine, attention deficit hyperactivity disorder
- MeSH terms
- Mental Disorders, Drug Therapy, Combination, Humans, Narcotic Antagonists, Psychotherapy, Antipsychotic Agents, Comorbidity, Diagnosis, Dual (Psychiatry), Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
